Pacific Biosciences of California Inc reports results for the quarter ended December 31 - Earnings Summary

Pacific Biosciences of California

13/02/2025 22:01

* Pacific Biosciences of California Inc  PACB.OQ  reported
quarterly adjusted earnings of 51 cents​​ per share for the
quarter ended December 31, higher than the same quarter last
year, when the company reported EPS of -31 cents.  The mean
expectation of sixteen analysts for the quarter was for a loss
of 21 cents per share. Wall Street expected results to range
from -29 cents to -16 cents per share.
    * Revenue fell 32.8% to $39.22 million from a year ago;
analysts
expected $40.16 million. 
    * Pacific Biosciences of California Inc's reported EPS for
the
quarter was 1 cent​.
    * The company reported quarterly net income of $3.57
million.
    * Pacific Biosciences of California Inc shares had fallen
by 25.7%
this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 9
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Pacific
Biosciences of California Inc is $2.50 
This summary was machine generated from LSEG data February 13 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.21          0.51           Beat
 Sep. 30 2024      -0.22          -0.22          Met
 Jun. 30 2024      -0.23          -0.64          Missed
 Mar. 31 2024      -0.28          -0.29          Missed